| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |